| scholarly article | Q13442814 |
| P50 | author | Melissa C. Skala | Q90631749 |
| Alex J Walsh | Q90986913 | ||
| P2093 | author name string | Carlos L Arteaga | |
| Donna J Hicks | |||
| Rebecca S Cook | |||
| H Charles Manning | |||
| Alec Lafontant | |||
| P2860 | cites work | Fluorescence lifetime imaging of free and protein-bound NADH | Q24563134 |
| On the Origin of Cancer Cells | Q27861025 | ||
| Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes | Q28193039 | ||
| Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors | Q28240530 | ||
| Acute stimulation of glucose metabolism in mice by leptin treatment | Q59079790 | ||
| Autofluorescence Microscopy of Fresh Cervical-Tissue Sections Reveals Alterations in Tissue Biochemistry with Dysplasia¶ | Q60407141 | ||
| Isocitrate dehydrogenase activity and its regulation by estradiol in tissues of rats of various ages | Q68485128 | ||
| Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study | Q72559241 | ||
| Subcellular heterogeneity of mitochondrial function and dysfunction: evidence obtained by confocal imaging | Q76377715 | ||
| ??? | Q28262062 | ||
| The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase | Q28373346 | ||
| Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer | Q29617440 | ||
| Two-photon fluorescence spectroscopy and microscopy of NAD(P)H and flavoprotein | Q30833030 | ||
| Proteome analysis for the identification of in vivo estrogen-regulated proteins in bone | Q30866919 | ||
| Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer | Q33220463 | ||
| Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy | Q33353929 | ||
| Longitudinal optical imaging of tumor metabolism and hemodynamics | Q33632108 | ||
| Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer | Q33641143 | ||
| PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib | Q33933626 | ||
| Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer | Q33986198 | ||
| Molecular mechanisms underlying ErbB2/HER2 action in breast cancer | Q34130548 | ||
| Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts | Q34164724 | ||
| Ex vivo optical metabolic measurements from cultured tissue reflect in vivo tissue status | Q34464153 | ||
| PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake. | Q34914187 | ||
| 18FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R/IR inhibitor, in preclinical mouse models of lung cancer | Q35065961 | ||
| Glucose metabolism measured by [¹⁸F]fluorodeoxyglucose positron emission tomography is independent of PTEN/AKT status in human colon carcinoma cells | Q35116828 | ||
| Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer | Q35252217 | ||
| Time-resolved fluorescence microscopy | Q35992536 | ||
| In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia | Q36288673 | ||
| Akt-dependent transformation: there is more to growth than just surviving | Q36313173 | ||
| Picosecond fluorescence lifetime of the coenzyme of D-amino acid oxidase | Q36587469 | ||
| Probing the microenvironment of mammary tumors using multiphoton microscopy | Q36654199 | ||
| Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status | Q37306101 | ||
| Two-photon autofluorescence dynamics imaging reveals sensitivity of intracellular NADH concentration and conformation to cell physiology at the single-cell level | Q37337668 | ||
| Inhibition of mammalian target of rapamycin is required for optimal antitumor effect of HER2 inhibitors against HER2-overexpressing cancer cells | Q37456176 | ||
| Optical imaging of metabolism in HER2 overexpressing breast cancer cells | Q39410475 | ||
| 18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice | Q39786337 | ||
| Trastuzumab-induced HER reprogramming in "resistant" breast carcinoma cells | Q39874639 | ||
| Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB ligands and remain dependent on the ErbB receptor network | Q40093663 | ||
| Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals | Q40224778 | ||
| Metabolic mapping of MCF10A human breast cells via multiphoton fluorescence lifetime imaging of the coenzyme NADH. | Q40365851 | ||
| Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action | Q42523855 | ||
| Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex | Q43568370 | ||
| Impact of animal handling on the results of 18F-FDG PET studies in mice. | Q46109682 | ||
| A small animal positron emission tomography study of the effect of chemotherapy and hormonal therapy on the uptake of 2-deoxy-2-[F-18]fluoro-D-glucose in murine models of breast cancer. | Q53496592 | ||
| Prospective study of positron emission tomography for evaluation of the activity of lapatinib, a dual inhibitor of the ErbB1 and ErbB2 tyrosine kinases, in patients with advanced tumors. | Q53515318 | ||
| The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. | Q54115075 | ||
| Effect of nicotinamide adenine dinucleotide on the oxidation-reduction potentials of lipoamide dehydrogenase from pig heart. | Q54669100 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 6164-6174 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer | |
| P478 | volume | 73 |
| Q55284968 | A Radiosensitizing Inhibitor of HIF-1 alters the Optical Redox State of Human Lung Cancer Cells In Vitro. |
| Q36301593 | A quantitative framework for the analysis of multimodal optical microscopy images |
| Q27010314 | Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence |
| Q41285978 | Autofluorescence flow sorting of breast cancer cell metabolism |
| Q41068676 | Autofluorescence imaging captures heterogeneous drug response differences between 2D and 3D breast cancer cultures |
| Q50662107 | Autofluorescence imaging identifies tumor cell-cycle status on a single-cell level. |
| Q57180667 | Autofluorescence lifetime imaging of cellular metabolism: Sensitivity toward cell density, pH, intracellular, and intercellular heterogeneity |
| Q38848135 | Blind deconvolution estimation of fluorescence measurements through quadratic programming. |
| Q34611146 | Breast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI. |
| Q64974078 | Can we use rapid lifetime determination for fast, fluorescence lifetime based, metabolic imaging? Precision and accuracy of double-exponential decay measurements with low total counts. |
| Q64249127 | Cellular Metabolic Heterogeneity In Vivo Is Recapitulated in Tumor Organoids |
| Q57492608 | Characterization of NAD(P)H and FAD autofluorescence signatures in a Langendorff isolated-perfused rat heart model |
| Q97905729 | Classification of T-cell activation via autofluorescence lifetime imaging |
| Q35105141 | Collagen density and alignment in responsive and resistant trastuzumab-treated breast cancer xenografts |
| Q39257470 | Context-dependent intravital imaging of therapeutic response using intramolecular FRET biosensors. |
| Q36051797 | Correlating two-photon excited fluorescence imaging of breast cancer cellular redox state with seahorse flux analysis of normalized cellular oxygen consumption |
| Q51539021 | Correlative NAD(P)H-FLIM and oxygen sensing-PLIM for metabolic mapping. |
| Q47836759 | Deciphering metabolic rewiring in breast cancer subtypes |
| Q35774073 | Deconvolution of fluorescence lifetime imaging microscopy by a library of exponentials |
| Q37103173 | Depth-resolved analytical model and correction algorithm for photothermal optical coherence tomography |
| Q36438337 | Drug response in organoids generated from frozen primary tumor tissues |
| Q37096669 | ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer |
| Q47227370 | Evaluating Cell Metabolism Through Autofluorescence Imaging of NAD(P)H and FAD. |
| Q90537127 | Fluorescence Lifetime Imaging Ophthalmoscopy of the Retinal Pigment Epithelium During Wound Healing After Laser Irradiation |
| Q58120920 | Fluorescence lifetime shifts of NAD(P)H during apoptosis measured by time-resolved flow cytometry |
| Q99581494 | High-resolution microscopy for imaging cancer pathobiology |
| Q93090628 | High-speed imaging of transient metabolic dynamics using two-photon fluorescence lifetime imaging microscopy |
| Q35029198 | High-throughput measurements of the optical redox ratio using a commercial microplate reader |
| Q51091500 | Hydrogen peroxide modulates energy metabolism and oxidative stress in cultures of permanent human Müller cells MIO-M1. |
| Q37130950 | Imaging Sensitivity of Quiescent Cancer Cells to Metabolic Perturbations in Bone Marrow Spheroids |
| Q38213988 | Imaging hallmarks of cancer in living mice |
| Q38809622 | In Vivo Autofluorescence Imaging of Tumor Heterogeneity in Response to Treatment. |
| Q36934018 | In Vivo Visualization of Stromal Macrophages via label-free FLIM-based metabolite imaging |
| Q33915825 | In vivo hyperspectral imaging of microvessel response to trastuzumab treatment in breast cancer xenografts. |
| Q59330237 | In vivo multiphoton microscopy detects longitudinal metabolic changes associated with delayed skin wound healing |
| Q51024473 | In vivo nonlinear optical imaging to monitor early microscopic changes in a murine cutaneous squamous cell carcinoma model. |
| Q34848837 | In vivo nonlinear spectral imaging as a tool to monitor early spectroscopic and metabolic changes in a murine cutaneous squamous cell carcinoma model. |
| Q60907619 | In-vivo correlations between skin metabolic oscillations and vasomotion in wild-type mice and in a model of oxidative stress |
| Q56341979 | Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer |
| Q36912011 | Label-free imaging of metabolism and oxidative stress in human induced pluripotent stem cell-derived cardiomyocytes |
| Q51367303 | Label-free in vivo cellular-level detection and imaging of apoptosis. |
| Q96642628 | Label-free, High-Resolution Optical Metabolic Imaging of Human Cervical Precancers Reveals Potential for Intraepithelial Neoplasia Diagnosis |
| Q58774468 | Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer |
| Q64073663 | Low dose photodynamic therapy harmonizes with radiation therapy to induce beneficial effects on pancreatic heterocellular spheroids |
| Q46001481 | MALDI Mass Spectrometry Imaging for Evaluation of Therapeutics in Colorectal Tumor Organoids. |
| Q33621051 | Magnetization Transfer MRI Contrast May Correlate with Tissue Redox State in Prostate Cancer |
| Q96155574 | Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment |
| Q36252747 | Metabolic Imaging of Head and Neck Cancer Organoids |
| Q64245167 | Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications |
| Q33807803 | Metabolic fingerprinting of bacteria by fluorescence lifetime imaging microscopy. |
| Q104073561 | Metabolomics revealed the influence of breast cancer on lymphatic endothelial cell metabolism, metabolic crosstalk, and lymphangiogenic signaling in co-culture |
| Q53438540 | Metaboloptics: Visualization of the tumor functional landscape via metabolic and vascular imaging. |
| Q47308551 | Mitochondrial matrix pH as a decisive factor in neurometabolic imaging |
| Q33812892 | Multicolor two-photon imaging of endogenous fluorophores in living tissues by wavelength mixing. |
| Q92531655 | Multiphoton FLIM imaging of NAD(P)H and FAD with one excitation wavelength |
| Q55346617 | Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial Cells. |
| Q91425979 | NADH Autofluorescence-A Marker on its Way to Boost Bioenergetic Research |
| Q51016078 | NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome. |
| Q88409664 | NMR-based metabolomics of biofluids in cancer |
| Q47146704 | Near-simultaneous intravital microscopy of glucose uptake and mitochondrial membrane potential, key endpoints that reflect major metabolic axes in cancer. |
| Q55436169 | Near-simultaneous quantification of glucose uptake, mitochondrial membrane potential, and vascular parameters in murine flank tumors using quantitative diffuse reflectance and fluorescence spectroscopy. |
| Q51251371 | Non-invasive metabolic imaging of melanoma progression. |
| Q57340826 | Nonlinear optical microscopy: endogenous signals and exogenous probes |
| Q91674133 | Nonparametric empirical Bayesian framework for fluorescence-lifetime imaging microscopy |
| Q50632568 | On chip two-photon metabolic imaging for drug toxicity testing. |
| Q36922301 | Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response. |
| Q64951484 | Optical Redox Imaging of Fixed Unstained Muscle Slides Reveals Useful Biological Information. |
| Q57210175 | Optical Redox Imaging of Lonidamine Treatment Response of Melanoma Cells and Xenografts |
| Q28540413 | Optical metabolic imaging of treatment response in human head and neck squamous cell carcinoma |
| Q41205147 | Optical metabolic imaging quantifies heterogeneous cell populations |
| Q37429091 | Optical redox ratio identifies metastatic potential-dependent changes in breast cancer cell metabolism. |
| Q49585331 | Oxidative stress via inhibition of the mitochondrial electron transport and Nrf-2-mediated anti-oxidative response regulate the cytotoxic activity of plumbagin. |
| Q92594565 | Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation |
| Q49544341 | Perspectives of Reprogramming Breast Cancer Metabolism |
| Q30408505 | Photothermal optical lock-in optical coherence tomography for in vivo imaging |
| Q53698637 | Protein-bound NAD(P)H Lifetime is Sensitive to Multiple Fates of Glucose Carbon. |
| Q39793364 | Quadratic blind linear unmixing: A graphical user interface for tissue characterization |
| Q93015658 | Quantifying Age-Related Changes in Skin Wound Metabolism Using In Vivo Multiphoton Microscopy |
| Q52654978 | Quantitative evaluation of redox ratio and collagen characteristics during breast cancer chemotherapy using two-photon intrinsic imaging. |
| Q34205196 | Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer. |
| Q36941952 | Radiation Promptly Alters Cancer Live Cell Metabolic Fluxes: An In Vitro Demonstration. |
| Q58545038 | Real-time detection of breast cancer at the cellular level |
| Q35740663 | Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer. |
| Q37417990 | Spatial dynamics of SIRT1 and the subnuclear distribution of NADH species |
| Q36083518 | Temporal binning of time-correlated single photon counting data improves exponential decay fits and imaging speed |
| Q42746278 | The metabolic interaction of cancer cells and fibroblasts - coupling between NAD(P)H and FAD, intracellular pH and hydrogen peroxide |
| Q33823191 | The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis |
| Q89993226 | Tracking Photodynamic- and Chemotherapy-Induced Redox-State Perturbations in 3D Culture Models of Pancreatic Cancer: A Tool for Identifying Therapy-Induced Metabolic Changes |
| Q41069821 | Transient absorption imaging of hemes with 2-color, independently tunable visible-wavelength ultrafast source |
| Q35117423 | Tumor mechanics and metabolic dysfunction |
| Q37153734 | Two-photon excited fluorescence of intrinsic fluorophores enables label-free assessment of adipose tissue function |
| Q94340226 | UEG Week 2016 Poster Presentations |
| Q52657362 | Visualization of breast cancer metabolism using multimodal non-linear optical microscopy of cellular lipids and redox state. |
| Q28073655 | Zebrafish small molecule screens: Taking the phenotypic plunge |
| Q37295289 | mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2/PIK3CA-hyperactive breast cancer |
| Q90625429 | miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer |
Search more.